Orgenesis
Vered Caplan is the CEO of Orgenesis, a position they have held since December 2010. Prior to Orgenesis, they were with Inmotion LTD from January 2010 to December 2010 as business development. Ms. Caplan was also a founding board member of Nehora from January 2009 to December 2014 and the CEO of Kamedis Ltd. from January 2009 to December 2014.
At Nehora, Ms. Caplan was responsible for the development of an innovative technology that allowed non-invasive continuous monitoring of Hematocrit (Hct), based on an optical technology. Vered also managed the company from being a local cosmetic company to an international dermatology company with a 10 fold growth in sales, medical regulatory approvals, medical grade manufacturing and international marketing.
Ms. Caplan has extensive experience in business development, management, and marketing. Vered is a leading expert in the areas of Bio-physics and Bio-medical engineering.
Efrat Assa Kunik - General Manager, Evan Fishman - Chief Financial Officer, and Greg Roumeliotis - VP of Global Business Development report to Vered Caplan.
This person is not in any offices
Orgenesis
Orgenesis is a pioneering global biotech company featuring a unique Cell & Gene Therapy Biotech Platform. The company is focused on unlocking the power of cell and gene therapies with this platform to provide life-changing treatments at the Point of Care (POCare) to large numbers of patients at drastically reduced costs.